Synopsys Inc. stocks have been trading up by 12.77 percent amid bullish sentiment around its AI-driven chip design leadership.
Click Here for a Millionaire's POV on Trading SNPS
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways
- Multi‑year OpenAI partnership will embed GPT‑Synopsys into core design tools, tying SNPS more tightly to the AI build‑out.
- A multi‑year IP and tools deal with Amazon, worth over $1B, strengthens recurring revenue visibility for SNPS.
- At 2026 Investor Day, SNPS guided to ~15% revenue growth to about $11.15B in FY27 and ~44% non‑GAAP operating margin, plus ~$1B in near‑term buybacks.
- Management’s FY27 outlook for SNPS tops Street EPS and revenue estimates, reinforcing the long‑term growth story.
- HSBC moved SNPS to Buy and hiked its target to $700, flagging a shift toward a higher‑growth, AI‑driven royalty model.
Live Update At 15:02:50 EDT: On Thursday, October 01, 2026 Synopsys Inc. stock [NASDAQ: SNPS] is trending up by 12.77%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
SNPS has been in a strong uptrend. In mid‑September, Synopsys shares were closing around $392–$401. By 2026/09/30, the stock finished at $434.94. On 2026/10/01, SNPS ripped higher again, closing at $490.24 after trading as high as $496.95. That is a sharp multi‑session leg higher, signaling fresh demand after the AI news and long‑term guidance.
Intraday, the 5‑minute tape shows SNPS holding most of its gains. After an early spike off a $462 low, buyers kept stepping in on dips around $480–$485, and the stock churned near the highs into the close. That kind of tight consolidation near the top of the day often tells traders that strong hands are in control rather than fast money bailing out.
More Breaking News
- INFY Extends ABN AMRO AI Deal As ADRs Stay Under Pressure
- CIFR Stock Pulls Back As Traders Weigh Heavy Losses And High Valuation
- BBAI Stock Steadies As Insider Ownership Filings Hit The Tape
- QSI Stock Pops As Proteus Platform Outperforms And Roadshow Expands
Fundamentally, Synopsys is not cheap. The P/E around 72.7 and price‑to‑sales near 8.45 say traders are paying up for growth. But margins are fat: gross margin sits at 72.4%, and EBITDA margin is 32.2%. Revenue has been growing above 20% annually over three years, backed by solid free cash flow and moderate leverage. For active traders, SNPS trades like a high‑quality, high‑expectation AI infrastructure name where momentum and news flow really matter.
Why Traders Are Watching SNPS Right Now
SNPS just put on the kind of show that grabs every momentum trader’s attention. At its 2026/09/30 Investor Day, Synopsys rolled out an AI‑centric roadmap that ties almost every growth lever back to artificial intelligence. Management guided to about 15% revenue growth, reaching roughly $11.15B in FY27, with a hefty ~44% non‑GAAP operating margin. For a software‑like EDA and IP business at scale, those are elite numbers.
On top of that, Synopsys expects FY27 revenue of $11.1–$11.2B versus prior Street expectations of $10.8B, and adjusted EPS of $19.04–$19.12 versus $17.69. That is not a small beat; it is a reset higher for the whole earnings curve. Traders know that when guidance clears the bar by that much, analysts tend to chase estimates up, which can keep a bid under SNPS for a while.
The OpenAI deal is the sizzle. SNPS and OpenAI are co‑developing GPT‑Synopsys, an AI model wired directly into Synopsys’ design tools. That makes SNPS feel less like a sleepy EDA vendor and more like a core AI engineering platform. Then there is Amazon. Synopsys signed a multi‑year IP, EDA, and AI tools agreement with Amazon, worth over $1B, supporting Amazon’s custom silicon for AI and cloud. SNPS shares already popped about 2% on that announcement, showing the market cares about this pipeline.
Layer in expanded collaboration with TSMC on its most advanced nodes and SNPS starts to look embedded across the AI supply chain: hyperscalers, foundry, design tools, and IP. For traders, that breadth makes Synopsys one of the cleaner pure‑play AI infrastructure charts in large‑cap tech.
Conclusion
For active traders, the most important piece of the SNPS story is not just the news but how it lines up with the chart and the cash. Synopsys is targeting mid‑teens revenue growth from FY26–FY30, plus mid‑20% gains in adjusted EPS and free cash flow. Management expects about $3.1B of free cash flow in FY27 on only $500M of capital spending, which is a powerful spread. They also plan to return up to 50% of free cash flow through 2030, with roughly $1B of buybacks in the near term. That creates a steady bid underneath the stock when markets get shaky.
The HSBC upgrade to Buy with a $700 target, tied to a higher‑growth design IP royalty model, showed how quickly the Street can rethink SNPS when the AI story tightens up. The stock’s ~4% jump on that call and the later surge on the Amazon and OpenAI news confirm there is real trading momentum behind the narrative.
Still, no ticker is a sure thing. Expectations are high, the P/E is rich, and any stumble on AI execution or macro demand can hit a premium name hard. That is where discipline matters. As Tim Sykes likes to say, “The market doesn’t care about your opinion, only your plan and your discipline.” Or as another trading mentor puts it, As Tim Bohen, lead trainer with StocksToTrade says, “If you’re still guessing at the end of your analysis, it’s probably not a trade worth taking.”. With SNPS, the story, numbers, and tape all line up bullish right now — but traders still need a clear plan, hard stops, and the willingness to walk away if the setup breaks. This analysis is for educational and research purposes only, not investment advice.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.